AIDS 2026 will be held in Rio de Janeiro, Brazil from 26-31 July 2026. We'll be attending to present the latest data from our industry leading portfolio and pipeline, and also connect with our community partners from around the world.

This page will be updated soon with more information.

OUR ULTIMATE GOAL: TO END THE HIV EPIDEMIC

At ViiV healthcare, our goal is ambitious, yet clear: we want to end the HIV epidemic. We believe we have the tools to achieve this goal through continuous innovation, talented people and global partnerships that help us reach the communities that are disproportionately impacted by HIV. We must keep investing in the global HIV response.

There’s a misconception that HIV Is a solved problem- it is not, and remains a significant global health challenge. But with collaboration, driven by deep community engagement and strategic partnerships, we move one step closer to ending the epidemic.

For people living with HIV. Resources and information about living well with HIV.

For news and media. Latest news and press releases via our media centre.

For healthcare professionals, Information about ViiV medicines and data.

NP-GBL-HVX-COCO-240034 | February 2026

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.